QuiVad

Home / Sweden / Re:NewCell AB

Re:NewCell AB

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 3.48% on February 16, 2023. The shaded band is the year shown above.

February 23, 2022 today

Open positions

No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.

History of disclosures

48 disclosures on record for this share.
DateFund% of capitalEnd of publication
February 13, 2024GSA Capital Partners LLP1.24%still open
February 7, 2024GSA Capital Partners LLP1.12%still open
February 5, 2024GSA Capital Partners LLP1.00%still open
January 31, 2024GSA Capital Partners LLP0.93%still open
January 29, 2024GSA Capital Partners LLP0.84%still open
January 22, 2024GSA Capital Partners LLP0.71%still open
January 17, 2024GSA Capital Partners LLP0.61%still open
January 15, 2024GSA Capital Partners LLP0.52%still open
November 22, 2023Alcur Fonder AB0.53%still open
November 13, 2023Arrowstreet Capital Limited Partnership0.91%still open
November 8, 2023Arrowstreet Capital Limited Partnership0.87%still open
November 7, 2023Arrowstreet Capital Limited Partnership0.77%still open
November 6, 2023Arrowstreet Capital Limited Partnership0.65%still open
June 30, 2023Franklin Templeton Investment Management Limited0.57%still open
March 24, 2023Citadel Advisors LLC0.59%still open
March 23, 2023Franklin Templeton Investment Management Limited0.69%still open
March 23, 2023Citadel Advisors LLC0.60%still open
March 22, 2023Franklin Templeton Investment Management Limited1.12%still open
March 22, 2023Citadel Advisors LLC0.56%still open
February 27, 2023Acadian Asset Management LLC0.54%still open
February 23, 2023Acadian Asset Management LLC0.66%still open
February 23, 2023Arrowstreet Capital Limited Partnership0.52%still open
February 16, 2023Citadel Advisors LLC0.58%still open
January 31, 2023Acadian Asset Management LLC0.78%still open
January 9, 2023Arrowstreet Capital Limited Partnership0.50%still open
December 13, 2022Acadian Asset Management LLC0.81%still open
December 7, 2022Franklin Templeton Investment Management Limited1.62%still open
December 6, 2022Citadel Advisors LLC0.53%still open
November 21, 2022Acadian Asset Management LLC0.71%still open
November 7, 2022Franklin Templeton Investment Management Limited1.58%still open
September 2, 2022Acadian Asset Management LLC0.60%still open
August 2, 2022Franklin Templeton Investment Management Limited1.70%still open
July 27, 2022Franklin Templeton Investment Management Limited1.60%still open
May 17, 2022Acadian Asset Management LLC0.56%still open
May 9, 2022Franklin Templeton Investment Management Limited1.50%still open
May 6, 2022Franklin Templeton Investment Management Limited1.44%still open
April 28, 2022Franklin Templeton Investment Management Limited1.40%still open
April 8, 2022Franklin Templeton Investment Management Limited1.32%still open
April 2, 2022Acadian Asset Management LLC0.60%still open
March 17, 2022Franklin Templeton Investment Management Limited1.20%still open
March 11, 2022Franklin Templeton Investment Management Limited1.14%still open
March 9, 2022Franklin Templeton Investment Management Limited1.01%still open
March 8, 2022Franklin Templeton Investment Management Limited0.94%still open
March 4, 2022Franklin Templeton Investment Management Limited0.81%still open
March 2, 2022Franklin Templeton Investment Management Limited0.73%still open
March 1, 2022Acadian Asset Management LLC0.50%still open
February 28, 2022Franklin Templeton Investment Management Limited0.61%still open
February 23, 2022Franklin Templeton Investment Management Limited0.50%still open

Other companies sold short in Sweden

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Re:NewCell AB, source Finansinspektionen, data as at February 13, 2024, https://www.quivad.com/action/re-newcell-ab